Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

NCT03146403 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped 2017 business decision to cease GEN-003 spending.

Conditions

Genital Herpes
HSV-2 Infection

Interventions

BIOLOGICAL: GEN-003
BIOLOGICAL: Matrix-M2
OTHER: 0.9% normal saline

Sponsor

Genocea Biosciences, Inc.